Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ISU104 |
Synonyms | |
Therapy Description |
ISU104 is a human monoclonal antibody targeting ERBB3 (HER3), potentially inhibits downstream signaling, cell proliferation, and tumor growth (PMID: 33782100). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ISU104 | ISU-104|ISU 104|Barecetamab | HER3 (ERBB3) Antibody 23 | ISU104 is a human monoclonal antibody targeting ERBB3 (HER3), potentially inhibits downstream signaling, cell proliferation, and tumor growth (PMID: 33782100). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|